Skip to main content
Log in

Palliativmedizin bei nichtmalignen chronisch pulmonalen Erkrankungen

Nur Behandlung von Dyspnoe?

Palliative treatment for benign chronic pulmonary diseases

Only treatment of dyspnea?

  • Leitthema
  • Published:
Der Pneumologe Aims and scope

Zusammenfassung

Patienten mit nichtonkologischen Erkrankungen zeichnen sich im fortgeschrittenen und lebenslimitierenden Erkrankungsstadium durch eine hohe Symptomlast aus. Palliativmedizinische Behandlungskonzepte werden bei diesen Patienten in Deutschland noch zu wenig und oft zu spät eingesetzt. Die unterschiedlichen Symptome (Dyspnoe, Husten, Kachexie, Fatigue, Angst und Depression) und deren medikamentöse und nichtmedikamentöse Kontrolle werden dargestellt. Die Herausforderung bei der Betreuung von Patienten mit chronisch obstruktiver Atemwegserkrankung (COPD) liegt darin, den palliativmedizinischen Bedarf zu erkennen und interdisziplinär umzusetzen.

Abstract

Patients with advanced stage, non-oncological incurable and life-threatening diseases, such as chronic obstructive pulmonary disease (COPD), are characterized by the presence of many symptoms. Palliative care concepts for these patients are not yet available throughout Germany and are often implemented too late. The different symptoms, such as dyspnea, coughing, cachexia, fatigue, fear and depression as well as the pharmaceutical and non-pharmaceutical management are presented. The challenge for the care of patients with advanced stage COPD is to recognize the palliative care requirements and to implement the appropriate measures in an interdisciplinary manner.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blindermann CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ (2010) Early palliative care for patients with metastatic non-small-lung cancer. N Engl J Med 363:733–742

    Article  CAS  PubMed  Google Scholar 

  2. Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL, Bourbeau J, Calverley PM, Gift AG, Harver A, Lareau SC, Mahler DA, Meek PM, O’Donnell DE (2012): An official American Thoracic Society Statement: update on the mechanism, assessment and management of dyspnea. Am J Respir Crit Care Med 185(4):435–452

    Article  PubMed  Google Scholar 

  3. Gupta R, Goldstein R, Brooks D (2006) The acute effects of a rollator in individuals in COPD. J Cardiopulmrehabil 26:107–111

    Google Scholar 

  4. Neder JA, Sword D, Ward SA, Mackay E, Cochrane LM, Clark CJ (2002) Home based neuromuscular electrical Stimulation as a new rehabilitative strategy for serverely disabled patients with chronic obstructive pulmonary disease (COPD). Thorax 57:333–337

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Galbraith S, Fagan P, Perkins P, Lynch A, Booth S (2010) Does the use of a handheld fan improve chronic dyspnea? A randomized, controlled, crossover trial. J Pain Symptom Manag 39:831–838

    Article  Google Scholar 

  6. Jennings AL, Davies AN, Higgins JP, Gibbs JS, Broadley KE (2002) A systematic review of the use of opiods in the management of dyspnoea. Thorax 57:939–949

    Article  PubMed  PubMed Central  Google Scholar 

  7. Abernethy AP, Currow DC, Frith P et al (2003) Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ 327:523–528

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Simon ST, Higginsons IJ, Booth S et al (2010) Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database Syst Rev, Issue 1. Art. No.:CD007354

    PubMed  Google Scholar 

  9. Abernethy AP, Mc Donald CF, Frith PA et al (2010) Effect of palliative oxygen verus room air in relief of breathlessness in patients with refractory dyspnoea: a doubl-blind, randomized controlled trial. Lancet 376:784–793

    Article  PubMed  PubMed Central  Google Scholar 

  10. Currow DC, Agar M, Smith J, Abernethy AP (2009) Does palliative home oxygen improve dyspnoea? A consecutive cohort study. Palliat Med 23:309–316

    Article  CAS  PubMed  Google Scholar 

  11. Wee B, Browning J, Adams A et al (2012) Management of chronic cough in patients receiving palliative care: review of evidence and recommendations by a task group of the Association for Palliative Medicine of Great Britain and Ireland. Palliat Med 26:780–787

    Article  PubMed  Google Scholar 

  12. Kardos P, Berck H, Fuchs KH, Gillissen A, Klimek L, Morr H, Pfeiffer Kascha D, Schulze Werninghaus G, Sitter H, Voshaar T, Worth H (2010) Guidelines of the German Respiratory Society for diagnosis und treatment of adults suffering from acute or chronic cough. Pneumologie 64:701–711

    Article  CAS  PubMed  Google Scholar 

  13. Matthys H, Bleicher B, Bleicher U (1983) Dextromethorphan and codeine: objective assessment of antitussive activity in patients with chronic cough. J Int Med Res 11:92–100

    Article  CAS  PubMed  Google Scholar 

  14. Sanders RV, Kirkpatrick MB (1984) Prolongend suppression of cough after inhalation of lidocaine in a patient with sarcoid. JAMA 252:2456–2457

    Article  CAS  PubMed  Google Scholar 

  15. Gray-Donald K, Gibbons L, Shapiro SH, Macklem PT, Martin JG (1996) Nutrional status and martality in chronic obstructive pulmonary disease. Am J Respircrit Care Med 153:961–966

    Article  CAS  Google Scholar 

  16. Paddison JS, Effing TW, Quinn S, Frith PA (2013) Fatigue in COPD association with functional status and hospitalisations. Eur Respir J 41(3):565–570

    Article  PubMed  Google Scholar 

  17. Temel J, Currow D, Fearon K, Gleich L, Yan Y, Friend J, Abernethy A (2014) 1483O_PR – Anamorelin for the treatment of cancer anorexia-cachexia in NSCLC: Results from the phase 3 studies ROMANA 1 and 2. Ann Oncol 25(5):1–41

    Google Scholar 

  18. Miki K, Maekura R, Nagaya N, Kakazato M, Kimura H et al (2012) Grhelin treatment of cachectic patients with chronic obstructive pulmonary disease: a multicenter, randomized, double-blind, placebo-controlled trial. PLos ONE 7:e35708

    Article  PubMed  PubMed Central  Google Scholar 

  19. Budweiser S, Heinemann F, Meyer K, Wild PJ, Pfeifer M (2006) Weight gain in cachectic COPD patients receiving noninvasive positive-pressure ventilation. Respir Care 51:126–132

    PubMed  Google Scholar 

  20. Yennuarajalignam S, Palmer JL, Chacko R, Bruera E (2011) Factors associated with response to methylphenidate in advanced cancer patients. Oncologist 16:246–253

    Article  Google Scholar 

  21. Hynninen KM, Breitve MH, Wiborg AB, Pallesen S, NordhusI H (2005) Psychological charateristics of patients with chronic obstructive pulmonary disease: a review. J Psychosom Res 59:429–443

    Article  PubMed  Google Scholar 

  22. Argyropoulou P, Patakas D, Koukou A, Vasiliadis P, Georgopoulos D (1993) Buspirone effect on breathlessness and exercise performance in patients with chronic obstructive pulmonary disease. Respiration 60:216–220

    Article  CAS  PubMed  Google Scholar 

  23. Singh NP, Despars JA, Stansbury DW, Avalos K, Light RW (1993) Effects of buspirone on anxiety levels and exercise tolerance in patients with chronic airflow obstruction and mild anxiety. Chest 103:800–804

    Article  CAS  PubMed  Google Scholar 

  24. Borson S, McDonald GJ, Gayle T, Deffebach M, Lakshminaravan S, VanTuinen C (1992) Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease. Psychomatics 33:190–201

    Article  CAS  Google Scholar 

  25. Emery CF, Schein RL, Hauck ER, MacIntyre NR (1998) Psychological and cognitive outcomes of a randomized trial of exercise among patients with chronic obstructive pulmonary disease. Health Psychol 17:232–240

    Article  CAS  PubMed  Google Scholar 

  26. Van Ede L, Yzermans CJ, Brouwer HJ. (1999) Prevalence of depression in patients with chronic obstructive pulmonary disease: a systematic review. Thorax 54:688–692

    Article  PubMed  PubMed Central  Google Scholar 

  27. Lacasse Y, Rousseau L, Maltais F (2001) Prevalence of depressive symptoms and depression in patients with severe oxygen-dependent chronic obstructive pulmonary disease. J Cardiopulmrehabil 21:80–86

    CAS  Google Scholar 

  28. Hill K, Geist R, Goldstein RS, Lacasse Y (2008) Anxiety and depression in end-stage COPD. Eur Respir J 31:667–677

    Article  CAS  PubMed  Google Scholar 

  29. Gore JM, Brophy CJ, Greenstone MA (2000) How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax 55:1000–1006

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Varkey B (2006) Unfulfilled palliative care needs of chronic pumonary disease patients. Curropinpulm Med 12:103–105

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T. Barchfeld.

Ethics declarations

Interessenkonflikt

T. Barchfeld gibt an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Barchfeld, T. Palliativmedizin bei nichtmalignen chronisch pulmonalen Erkrankungen. Pneumologe 13, 96–103 (2016). https://doi.org/10.1007/s10405-015-0016-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10405-015-0016-z

Schlüsselwörter

Keywords

Navigation